Results 171 to 180 of about 4,749 (223)

Traditional herbal medicine for opioid-induced constipation in patients with cancer: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Lee SH, Jin H, Kim EH, Yoon SW.
europepmc   +1 more source

Pathophysiological mechanisms, diagnostic innovations, and multimodal therapeutic strategies for slow transit constipation. [PDF]

BMC Gastroenterol
Tang X, Huang Y, Jiang T, Wu J, Wang K, Wu W.   +5 more
europepmc   +1 more source

Prospective, non-randomised, open-label pilot trial assessing feasibility, safety and treatment success of acupuncture in children with functional constipation: ACU-PILOT study protocol. [PDF]

BMJ Open
Bloem MN, Baaleman DF, Koppen IJN, Vlieger AM, de Lorijn F, Birch S, Nieuwdorp M, Benninga MA.   +7 more
europepmc   +1 more source

Dietary strategies for chronic constipation: smartly targeting hormonal and reflex pathways for optimal recovery. [PDF]

Front Pharmacol
Ribichini E, Scalese G, Mocci C, De Amicis N, Severi C.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Biofeedback, biofeedback plus fiber laxative, and biofeedback plus osmotic laxative regimens to treat constipation in patients with pelvic floor dyssynergia: A randomized controlled trial

Indian Journal of Gastroenterology, 2022
Pelvic floor dyssynergia (PFD) is one of the causes of chronic constipation. Laxative-based therapies are not very effective in treating this type of constipation. The therapeutic effectiveness of three therapeutic strategies, including biofeedback (BOF) alone, BOF+ fiber laxative (psyllium), and BOF +osmotic laxative (polyethylene glycol; [PEG]), was ...
Mohammad Sadegh Jamshidi, Habib Malekpour, Saeed Abdi, Faranak Farhan   +3 more
openaire   +2 more sources

Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

Advances in Therapy, 2022
Linaclotide, a selective agonist of guanylate cyclase C, was highly recommended for the treatment of irritable bowel syndrome with constipation (IBS-C). However, the cost-effectiveness of linaclotide in Chinese is not known, and this study aimed to assess the cost-effectiveness of linaclotide for patients with IBS-C.An economic evaluation was conducted
Dunming, Xiao, Yue, Zhang, Wanxin, Chen, Jianwei, Xuan, Yingyao, Chen   +4 more
openaire   +2 more sources